(Q50793077)

19 March 2018

title

Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. (English)

1 reference

19 March 2018

1 reference

7

1 reference

19 March 2018

author name string

P Manzoni

1

1 reference

19 March 2018

P Galletto

2

1 reference

19 March 2018

S Rizzollo

3

1 reference

19 March 2018

C Franco

4

1 reference

19 March 2018

E Gallo

5

1 reference

19 March 2018

R Antonucci

6

1 reference

19 March 2018

D Farina

8

1 reference

19 March 2018

publication date

1 May 2012

1 reference

19 March 2018

published in

Early Human Development

1 reference

19 March 2018

volume

88 Suppl 2

1 reference

19 March 2018

page(s)

S86-91

1 reference

19 March 2018

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Management of neonatal candidiasis. Neonatal Candidiasis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Amphotericin B-induced nephrotoxicity: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Guidelines for treatment of candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Liposomal amphotericin B in neonates with invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Amphotericin B lipid complex in pediatric patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Liposomal amphotericin B treatment for neonatal fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Amphotericin B lipid complex for neonatal invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2812%2970024-5

7 January 2021

10.1016/S0378-3782(12)70024-5

Identifiers

DOI

1 reference

19 March 2018

release_sxkq7l3d3nc57bfwnthd7x4ofm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sxkq7l3d3nc57bfwnthd7x4ofm

24 November 2022

mapped directly with Wikidata item

1 reference

19 March 2018